XML 25 R16.htm IDEA: XBRL DOCUMENT
v3.25.3

Share-Based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Share-Based Compensation | 7. Share-Based Compensation The Company has share-based compensation plans, which are more fully described in Note 9, Share-Based Compensation, to the Consolidated Financial Statements included in the 2024 10-K. During the nine months ended September 30, 2025, the Company granted its executives stock appreciation rights, or SARs, subject to service conditions and restricted stock units subject to service and performance conditions, or performance stock units. Share-based compensation expense amounted to $11.2 million and $13.0 million for the three months ended September 30, 2025 and 2024, respectively, and $33.2 million and $36.7 million for the nine months ended September 30, 2025 and 2024, respectively. As of September 30, 2025, the total unrecognized compensation cost related to all non-vested stock awards was $44.5 million and the related weighted-average period over which it is expected to be recognized is approximately 1.4 years. During the nine months ended September 30, 2025, the Company granted SARs with service conditions to its executives which generally vest over a two to three-year period. During the nine months ended September 30, 2025, the Company granted SARs with service conditions to consultants which generally vest over a three-year period. The fair value of all these SARs was determined on the date of grant using the Black-Scholes-Merton option pricing model. These grants are included in the table below. The following table summarizes the activity for all SARs under the Company’s share-based compensation plans for the nine months ended September 30, 2025:
|  | Number of Awards |  |  | Weighted-Average Exercise Price Per Award |  |  | Weighted- Average Remaining Contractual Term |  | Aggregate Intrinsic Value(1) |
|  | (in thousands) |  |  |  |  |  |  |  | (in millions) |
Outstanding as of December 31, 2024(2) |  |  | 11,002 |  |  | $ | 12.12 |  |  | 7.1 years |  | $ | — |
Granted(3) |  |  | 2,646 |  |  | $ | 7.72 |  |  |  |  |  |
Exercised |  |  | — |  |  | $ | — |  |  |  |  |  |
Forfeited/expired(4) |  |  | (472 | ) |  | $ | 16.42 |  |  |  |  |  |
Outstanding as of September 30, 2025(2) |  |  | 13,176 |  |  | $ | 11.09 |  |  | 7.2 years |  | $ | 3.6 |
Exercisable as of September 30, 2025(5) |  |  | 5,047 |  |  | $ | 15.12 |  |  | 6.8 years |  | $ | 0.4 |
Vested and expected to vest as of September 30, 2025(5) |  |  | 9,508 |  |  | $ | 12.16 |  |  | 7.9 years |  | $ | 2.3 |
(1) The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards. (2) Includes 3.9 million and 4.0 million performance condition SARs as of September 30, 2025 and December 31, 2024, respectively. (3) Includes less than 0.1 million performance condition SARs. (4) Includes 0.1 million performance condition SARs. (5) Includes 0.5 million performance condition SARs. There were no SARs granted during the three months ended September 30, 2025. The weighted-average grant date fair value of SARs granted during the three months ended September 30, 2024 was $5.36. The weighted-average grant date fair value of SARs granted during the nine months ended September 30, 2025 and 2024 was $4.14 and $4.52, respectively. There were no SARs exercised during the three and nine months ended September 30, 2025 and 2024. During the nine months ended September 30, 2025, the Company granted performance stock units to its executives which generally vest over a two to three-year period. The performance conditions include targets for local currency net sales, and adjusted earnings before interest, taxes, and depreciation and amortization. The following table summarizes the activities for all restricted stock units under the Company’s share-based compensation plans for the nine months ended September 30, 2025:
|  | Number of Shares |  |  | Weighted- Average Grant Date Fair Value Per Share |
|  | (in thousands) |  |  |  |
Outstanding and nonvested as of December 31, 2024(1) |  |  | 6,289 |  |  | $ | 12.56 |
Granted(2) |  |  | 1,779 |  |  | $ | 8.10 |
Vested |  |  | (2,999 | ) |  | $ | 14.55 |
Forfeited |  |  | (428 | ) |  | $ | 10.70 |
Outstanding and nonvested as of September 30, 2025(1) |  |  | 4,641 |  |  | $ | 9.74 |
Expected to vest as of September 30, 2025(3) |  |  | 4,227 |  |  | $ | 9.84 |
(1) Includes 1.6 million performance-based restricted stock units as of September 30, 2025, which represents the maximum amount that can vest. There were no performance-based restricted stock units outstanding as of December 31, 2024. (2) Includes 1.6 million performance-based restricted stock units. (3) Includes 1.2 million performance-based restricted stock units. The total vesting date fair value of restricted stock units which vested during the three months ended September 30, 2025 and 2024 was $2.6 million and $0.1 million, respectively. The total vesting date fair value of restricted stock units which vested during the nine months ended September 30, 2025 and 2024 was $22.4 million and $17.2 million, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration